16 Nov Uncategorized Vaccines could be a new frontier in KRAS targeting November 16, 2026 By hgesupplies 0 comments Nature Medicine, Published online: 13 November 2026; doi:10.1038/s41591-026-04772-1A convergence of therapeutic and technological adv...Continue reading
14 Nov Uncategorized Gut and urogenital microbiomes influence menopausal hormone therapy outcomes November 14, 2026 By hgesupplies 0 comments Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliation...Continue reading
12 Nov Uncategorized Effect of two common GVHD prophylaxis regimens on the gut microbiome in a randomized phase 3 trial November 12, 2026 By hgesupplies 0 comments BMT CTN 1801 study designIn the BMT CTN 1703 study, participants were randomized into two groups: the Tac/MTX arm received the standa...Continue reading
10 Nov Uncategorized Blood-based RNA biomarker for the early detection of ovarian cancer November 10, 2026 By hgesupplies 0 comments Webb, P. M. & Jordan, S. J. Global epidemiology of epithelial ovarian cancer. Nat. Rev. Clin. Oncol. 21, 389–400 (2024).Article ...Continue reading
08 Nov Uncategorized Hemodynamic effects of semaglutide in individuals with heart failure with preserved ejection fraction and obesity: a placebo-controlled randomized clinical trial November 8, 2026 By hgesupplies 0 comments Borlaug, B. A. et al. Obesity and heart failure with preserved ejection fraction: new insights and pathophysiological targets. Cardio...Continue reading
06 Nov Uncategorized A gait foundation model for prediction of multisystem health phenotypes from 3D skeletal motion November 6, 2026 By hgesupplies 0 comments Fritz, S. & Lusardi, M. White paper: ‘walking speed: the sixth vital sign’. J. Geriatr. Phys. Ther. 32, 46–49 (2009).Article ...Continue reading
04 Nov Uncategorized A live biotherapeutic product for adult allogeneic hematopoietic cell transplantation recipients: a partially randomized, placebo-controlled phase 1b trial November 4, 2026 By hgesupplies 0 comments EthicsStudy SER-155-001 was a two-part first-in-human phase 1b clinical study performed in accordance with Good Clinical Practice Gui...Continue reading
04 Nov Uncategorized A tumor transcriptomic atlas across eight decades of life reveals distinct features of early-onset colorectal cancer November 4, 2026 By hgesupplies 0 comments Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliation...Continue reading
04 Nov Uncategorized Perioperative ivonescimab with or without chemotherapy in resectable non-small cell lung cancer: a phase 2 trial November 4, 2026 By hgesupplies 0 comments Study design and patient dispositionThis nonrandomized, noncomparative, open-label, multicenter, phase 2 trial enrolled resectable NS...Continue reading